Lewis Stuart
2017 - NovaBay Pharmaceuticals
In 2017, Lewis Stuart earned a total compensation of $323.6K as Chief Commercial Officer at NovaBay Pharmaceuticals.
Compensation breakdown
| Option Awards | $264,384 |
|---|---|
| Salary | $25,000 |
| Stock Awards | $34,200 |
| Total | $323,584 |
Stuart received $264.4K in option awards, accounting for 82% of the total pay in 2017.
Stuart also received $25K in salary and $34.2K in stock awards.
Rankings
In 2017, Lewis Stuart's compensation ranked 13,155th out of 14,666 executives tracked by ExecPay. In other words, Stuart earned more than 10.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 13,155 out of 14,666 | 10th |
Division Manufacturing | 5,180 out of 5,772 | 10th |
Major group Chemicals And Allied Products | 1,879 out of 2,075 | 9th |
Industry group Drugs | 1,566 out of 1,731 | 10th |
Industry Pharmaceutical Preparations | 1,212 out of 1,333 | 9th |
Source: SEC filing on April 18, 2018.
Stuart's colleagues
We found four more compensation records of executives who worked with Lewis Stuart at NovaBay Pharmaceuticals in 2017.